BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018

WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) today applauds the House
of Representatives for passing the Pandemic and All-Hazards Preparedness
and Advancing Innovation Act of 2018 (H.R. 6378). The legislation would
re-authorize critical federal biodefense programs and agencies,
including the BioShield Special Reserve Fund (SRF), the Biomedical
Advanced Research and Development Authority (BARDA), and the Strategic
National Stockpile (SNS).

The following statement may be attributed to BIO President and CEO Jim

“Over the past 15 years, federal biodefense programs have spurred the
creation of dozens of medical countermeasures by the biotechnology
industry, greatly improving our nation’s preparedness to respond to the
many known and unknown chemical, biological, radiological and nuclear
threats (CBRN) facing our nation,” said BIO President and CEO Jim
Greenwood. “Yet with each passing week, the number and scale of these
threats continues to grow – whether from rogue regimes, terrorist
groups, emerging infectious diseases, or pandemics.”

“This legislation will provide much needed flexibility and
predictability for government agencies and their private sector
partners, by authorizing increased, multi-year funding for the BioShield
Special Reserve Fund and by empowering BARDA to better address CBRN
threat agents, pandemic influenza, emerging infectious diseases, and
antimicrobial resistance. Advance investments in preparedness and
medical countermeasure development will enhance our response efforts,
save lives, and be more cost effective in an emergency.”

“I applaud Congresswomen Susan Brooks (R-IN) and Anna G. Eshoo (D-CA),
along with House Energy and Commerce Committee Chairman Greg Walden
(R-OR) and Ranking Member Frank Pallone (D-NJ), for their bipartisan
leadership in advancing this vital legislation.”

About BIO

BIO is the world’s largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention
, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW
is BIO’s blog chronicling “innovations transforming our world” and the
BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter

Upcoming BIO Events







Patient and Health Advocacy Summit





Investor Forum

October 25-26, 2018

October 17-18, 2018

Washington, DC





San Francisco

CEO Investor Conference

International Convention

February 11-12, 2019

June 3-6, 2019

New York, NY





Philadelphia, PA